Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Some parents said they’re worried and deeply concerned after getting a letter Tuesday evening from the Darlington County ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

Now a museum, the Saranac Laboratory was established in 1894 and was the first in the United States dedicated to studying tuberculosis.

Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel ...

Tuberculosis (TB) has long been recognized as a disease of poverty, yet most TB research does not measure poverty in a meaningful way.

Tuberculosis may seem like a disease of the past—more associated with Victorian waifs and overcrowded tenements than medicine in the 21st century—but it’s definitely still with us.

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Tuberculosis (TB) has long been recognized as a disease of poverty, yet most TB research does not measure poverty in a ...

AI-based diagnostic tools, particularly deep learning models like Convolutional Neural Networks (CNNs), have demonstrated ...

Author John Green visited the University of Wisconsin’s Shannon Hall at Memorial Union on Feb. 18 to talk about the upcoming ...